Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Large-scale testing (Phase 3)Study completedNCT02012218
What this trial is testing

Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 61
Large-scale testing (Phase 3)Study completedNCT02158546
What this trial is testing

ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 447
Testing effectiveness (Phase 2)Looking for participantsNCT06633016
What this trial is testing

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Who this might be right for
Major Depressive Disorder
Autobahn Therapeutics, Inc. 230
Large-scale testing (Phase 3)Study completedNCT01173601
What this trial is testing

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 1,416
Large-scale testing (Phase 3)Ended earlyNCT03668600
What this trial is testing

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 230
Large-scale testing (Phase 3)Study completedNCT03188185
What this trial is testing

ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 278
Large-scale testing (Phase 3)Not Yet RecruitingNCT07781293
What this trial is testing

Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy

Who this might be right for
Major Depressive Disorder (MDD)Major Depressive Disorder With Psychotic Features
Bukwang Pharmaceutical 364
Large-scale testing (Phase 3)Study completedNCT05550532
What this trial is testing

Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 444